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velocity and in time constant of 17.2% and 22.7% respectively (p<0.05) with vestibular training. A pilot study
demonstrated figure skaters, due to their habituation, were less susceptible to motion sickness than were
controls (2.8 ± 2.8 vs. 16.2 ± 13.7; <0.01).
Conclusion: Since the overall GRADE of evidence is low, more research is needed before a strong
recommendation for visual-vestibular habituation can be given. Current evidence, although limited, does
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Abstract   
 
Background:  Motion sickness is a common problem experienced by much the 
population. Clinical treatments at this time are primarily pharmacological. Currently it is 
known that multiple exposures to motion sickness triggers can, over time, result in 
habituation and the patient can become free of symptoms. This repeated recurrence of 
sickness is not desirable or practical to daily living. Limited evidence is available for 
visual-vestibular habituation training that does not provoke the undesirable symptoms 
and can last for upwards of a year. 
 
Method:  An exhaustive search of available medical literature was conducted using 
Medline-OVID, CINAHL, VISIONCITE, EBMR Multifile and Web of Science using the 
keywords: motion sickness, visual vestibular and habituation. All articles published prior 
to 2000, non-English language and non-human trials were excluded by the search. 
Relevant articles were assessed for quality using GRADE.  
 
Results:  Three studies met inclusion criteria and were included in this systematic 
review. A pilot study consisting of 29 subjects demonstrated visual-vestibular habituation 
and reduction of motion sickness symptom scores in susceptible individuals from 13.0 ± 
4.4 to 1.5 ± 3.1 eighteen weeks after habituation. A randomized controlled, double blind, 
trial with 20 subjects demonstrated an overall reduction in the peak velocity and in time 
constant of 17.2% and 22.7% respectively (p<0.05) with vestibular training. A pilot study 
demonstrated figure skaters, due to their habituation, were less susceptible to motion 
sickness than were controls (2.8 ± 2.8 vs. 16.2 ± 13.7; <0.01). 
 
Conclusion:  Since the overall GRADE of evidence is low, more research is needed 
before a strong recommendation for visual-vestibular habituation can be given. Current 
evidence, although limited, does show promising results for this non-pharmacological 
treatment for motion sickness.  
 
Keywords:  Motion Sickness, Visual Vestibular, Habituation 
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Visual Vestibular Habituation as an Effective Treatment for Motion Sickness 
 
BACKGROUND  
 Individual susceptibility to motion sickness varies greatly. However, motion 
sickness is more common among women, and incidence ranges from < 1% on airplanes 
to nearly 100% on ships in rough seas and upon becoming weightless during space  
travel.1   Motion sickness is often accompanied by symptoms of nausea, dizziness, fatigue 
and diaphoresis. These symptoms can range from mild to moderate. Prolonged motion 
sickness can cause vomiting, which often does not relieve the symptoms. Although not 
all are affected, motion susceptible individuals can often become sick when traveling by 
any form of transportation.  The ramifications of this ailment can range from being an 
inconvenience to recreational boaters, to having major economical impacts on commuters 
traveling to and from a place of employment. 
Investigations that have examined the symptoms, predictors, and causes of motion 
sickness and the underlying mechanisms involved in motion sickness have revealed that a 
conflict of visual and vestibular information, as it relates to postural control and visual 
stabilization, is a critical factor.2-9 Because of the fact that subjects lacking peripheral 
vestibular function are immune to the stimuli that cause motion sickness as experienced 
by normal subjects, we know that the vestibular system plays a crucial role in the 
inducement of motion sickness.10  Vestibular habituation seems to be accompanied by 
reduced motion sickness. Thus, after a month of regular navigation, candidates for future 
maritime service become less sensitive to seasickness and show vestibulo-ocular reflex 
(VOR) habituation.11  Repetitive vestibular stimulation can therefore cause changes in 
VOR and at the same time a reduction in sensitivity to motion sickness.12 
8 
 
 Current treatments for motion sickness remain pharmacologic and generally 
require drug administration an hour before the offending stimulus. These treatments 
include the antihistamines, diphenhydramine and meclizine, as well as the anticholinergic 
scopolamine. The side effects of these medications are well known and not desirable. It 
has been shown that prolonged or repeated exposure to the motion sickness trigger or 
environment, provides habituation and decreased symptoms over time. However, it is not 
feasible or attractive for patients to undergo these repeated exposures which are 
accompanied by the symptoms mentioned above.  
 The aim of this systematic review is to help determine if the non-pharmacologic 
visual-vestibular habituation can serve as an effective clinical mean for the treatment of 
motion sickness.  
METHOD 
 An exhaustive search of the medical literature was conducted using Medline-
OVID, CINAHL, VISIONCITE, EBMR Multifile and Web of Science. The following 
terms were used to narrow the search: “Motion Sickness”, “Visual Vestibular” and 
“Habituation”.  Duplicate articles were removed. The search was then narrowed using the 
following criteria: English language and published prior to the year 2000. The 
bibliographies of the articles were further searched for relevant sources. The articles in 
this review were assessed for quality using the Grading of Recommendations 
Assessment, Development and Evaluation (GRADE) developed by the GRADE Working 
Group.13 
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RESULTS 
Initial result of the search yielded 46 articles for review. Six articles were 
excluded as duplicates leaving 40 articles. After screening relevant articles, a total of 3 
articles met inclusion criteria and were used in this systematic review. These articles 
included one randomized controlled trial and two observational studies. (See Table 1). 
Dai et al 
 In this clinical trial,14 the authors used a new approach where opposing visual and 
vestibular stimuli at low velocities (5-20º/s) and a low frequency (0.017 Hz) were used 
for habituation against motion sickness. It was further thought that these stimuli should 
be non-stressful, fast, effective and long lasting. Twenty nine subjects, 11 of whom had a 
previous history of motion sickness were enrolled in the trial. These 11 subjects were 
selected based off that history and placed into a motion sickness susceptible group. This 
group was further split into two groups, one with nine members and the other with two. 
Ten of these 11 subjects were female. The remaining 18 subjects (9 female & 9 male) 
formed a control group and were split evenly into two normal (Nl) groups, forming a total 
of four groups in this trial. There was no randomization or concealment. Study personnel 
were aware of the status of the subjects prior to placing them into groups. Subjects were 
also aware of which treatment group they were in. Patients were excluded if there was a 
history of vestibular or auditory dysfunction, migraine headaches, anxiety disorder, 
claustrophobia, seizures, severe vasovagal reactions or cardiovascular or autonomic 
disease.   Ages were similar between the groups and ranged from 25-45 years. There was 
a disparity in gender between the susceptible and normal groups as 10 of the 11 
susceptible subjects were female.14 
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 Baseline motion symptom scores were collected on all subjects, based on the 
average score obtained from motion sickness episodes over the past 1-2 years. Motion 
sickness scores were collected using a simplified Pensacola scale from 0 (no symptoms) 
to 20 (imminent emesis or strong sense of dizziness).15-18 These scores were reported 
verbally by each subject every 5-10s during chair rotation.14 
 Subjects were split into the following four groups: Normal group 1 (G1)-which 
tested with off-vertical axis rotation (OVAR) and habituation. Normal group 2 (G2)- 
tested with OVAR without habituation. Motion sickness susceptible (MSS) G1 tested 
OVAR and habituation. MSS G2 tested habituation only as they were determined to be 
incapable to tolerate the off-vertical axis rotation. The experiments were conducted using 
a rotating chair in a circular room where the patients were secured with a seatbelt and 
headband for immobilization. Black and white stripes were projected on the circular wall 
to elicit opticokinetic nystagmus (OKN) and opticokinetic after-nystagmus (OKAN). Eye 
measurements were recorded using a video-oculography camera over the right eye. Initial 
measurements were recorded during the baseline VOR testing to check for VOR gains 
and time constants (TC).14 
 OVAR testing was completed by sitting the subject in the chair that rotated at 
60º/s to the right in complete darkness. After disappearance of per-rotary nystagmus the 
chair continued to rotate and was tilted off the vertical axis 20º. The rotation was then 
stopped after the subject reported a motion sickness score of 20, or after 15 minutes had 
elapsed; whichever came first. OVAR testing occurred on days 1, 8, 22 and 29.14 
 Habituation consisted of the subject being placed in the rotating chair at a velocity 
of up to 20º/s where black and white stripes projected on the wall were oscillating at a 
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frequency of 0.017Hz so that this OKN stimulus was 180º out of sync with the subject’s 
VOR.  The habituation sessions occurred on days 15-19 for 40 min/day.14 
 Results after habituation showed decreased TC of 32% to 12.5 ± 2s for the MSS 
subjects and 21% to 12.8 ± 3.8s for normal subjects. This brought time constants to 
similar values between the groups; however this reduction was not as well maintained by 
the normal subjects. Initially VOR gain was overall higher in the susceptible group, but 
no overall change was noted during the habituation period for either group. Motion 
sickness scores of the susceptible group were higher initially as compared to the normal 
group, but after the 3rd and 4th OVAR test, the scores were approximately the same as 
seen in the normal group. A more significant drop in symptom scores was seen in the 
susceptible group. Prior to habituation the motion sickness scores for the susceptible 
group were 13.0 ± 4.4 and after habituation the scores were reduced to 1.5 ± 3.1 eighteen 
weeks later. Three MSS subjects reported some loss of habituation at four and a half 
months out with scores of 3, 4 and 10 out of 20, however the other 8 subjects were still 
free of motion sickness symptoms at that time. Five of the 11 susceptible subjects 
returned at 10 months post testing for data collection of VOR, TC and MS scores. TC 
were 18s (± 1.9s) before habituation, 10s (± 1.5s) after habituation and 14s (± 2.5s) 10 
months later. Motion sickness scores were 17 (± 3.1) before habituation and 5.2 (± 4.8) 
upon returning.14 
 The authors concluded the habituation technique used here has a rapid onset and 
causes little or no side effects to motion sickness susceptible individuals. They describe a 
high clinical potential in using this technique for treatment of motion sickness.  
 
12 
 
Clement et al 
 This double blind randomized controlled trial10 reviewed the effect of the amino 
acid acetylleucine for the reduction of nausea during head movements while rotating and 
facilitating vestibular habituation. They also investigated the relationship between motion 
sickness and subjective vertical. Twenty healthy male volunteers with an age range from 
20-40 years were enrolled in the trial. Subjects were excluded if they were found to have 
abnormalities in the visual, vestibular or cardiovascular systems.10 
 All subjects underwent initial control tests and vestibular training. For the control 
testing the subjects were placed in a rotating chair in the upright position. Subjects were 
tested in complete darkness. An infra-red light and video camera was mounted over each 
subject’s right eye to record eye movements and the left eye was covered. While the chair 
was immobile, a lighted dot that oscillated ±40º at 0.3 Hz was placed on the wall, testing 
for horizontal smooth eye pursuit.  Horizontal VOR was then evaluated using sinusoidal 
oscillation of the chair in yaw at 0.2 Hz with a peak velocity of 75.4º/s while fixating on a 
target that was placed in a position relative to the subjects head. VOR was further tested 
with the chair rotating in yaw from 0º/s to 180 º/s with an angular acceleration of 180 º/s2. 
 This generated per-rotary horizontal nystagmus. When the per-rotary nystagmus stopped, 
the chair was stopped producing a post-rotary nystagmus. The chair was then rotated in 
the opposite direction. The post-rotary nystagmus was used to establish baseline VOR for 
evaluating the long-term retention effects of VOR habituation after vestibular training. 
The Vestibular training composed of subjects being rotated in the chair at a velocity of 
180º/s. After one minute a metronome produced a signal every 5 seconds for the next one 
minute. This served as a cue for the subject to make a head and trunk movement to the 
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side at 45º and then return back upright. After the one minute of head and trunk 
movements, the chair was stopped and the post-rotary nystagmus was recorded. A one 
minute rest was given and the process was repeated but in the opposite direction of 
rotation. Each direction was considered a “run” and a series of 10 runs was completed 
with each subject.10 
After the control and vestibular training the subjects were divided evenly into a 
placebo group and an acetylleucine group. Subjects took their assigned capsules in the 
evening before the first vestibular training session, and then in the mornings and evenings 
for the next three weeks. Test sessions were then completed on days 1-6, 22, 35 and 65, 
with vestibular training sessions occurring on days 1-5.10 
 After the five vestibular habituation training sessions, 4 subjects from the placebo 
group and 5 subjects from the acetylleucine group appeared to have completely 
habituated to the rotational stimulus. The average number of runs tolerated by all subjects 
also increased during the habituation training from 3.2 ± 1.0 (SD) on day one to 6.4 ± 3.7 
runs on day 5. Motion sickness symptoms scores ranged on a scale from 0 for no 
symptoms to 51.19 These scores varied greatly between individual subjects, but overall 
decreased as the number of runs completed increased. There was no statistical difference 
between the groups in the motion sickness scores and number of runs completed. Overall 
results show a tolerance to motion sickness with repeated exposures.10 
 During post-rotary nystagmus no statistical difference was noted between the 
groups with gain and TC of the horizontal VOR. This data from both groups was then 
pooled for analysis. There was a large reduction in the peak velocity and time constant of 
the horizontal VOR over the course of the vestibular habituation. At the end of the 
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vestibular training, the overall reduction in the peak velocity and in time constant was 
17.2% and 22.7%, respectively (p<0.05), compared to initial values. At two weeks post 
habituation, these values still remained lower than original values.10 
 Overall the acetylleucine treatment did not seem to have an effect on reduction of 
nausea and facilitating vestibular habituation. Subjective vertical, although listed as one 
of the objectives of this study, was not relevant to this systematic review and will not be 
commented on further. 
Tanguy et al 
 This pilot study12 set out to evaluate the effect of figure skating on the functional 
plasticity of the vestibular system by comparing VOR characteristics and motion sickness 
susceptibility in figure skaters to those of control subjects. Twenty two female subjects 
ranging from 9-19 years of age were enrolled in the trial. Eleven were figure skaters who 
practiced 10 hours per week including performing counterclockwise rotations. The other 
group of 11 served as age and sex matched controls who engaged in some physical 
activity without high vestibular activation involvement. Subjects who had past or present 
history of otologic or neurological disorders were excluded from the study.12 
 All subjects underwent the same vestibular stimulation and motion sickness 
evaluation. Each subject was seated and immobilized in a rotary chair with the head held 
firmly in place with a bite-bar. Each subject then underwent three sequences in a single 
experimental session. All tests were performed in complete darkness. In the first 
sequence the chair did a sinusoidal rotation around a vertical axis for 120s (0.025Hz, 
amplitude ± 60º/s). The next two sequences were identical other than the direction of the 
rotation. For each direction of rotation the test was divided into three stages. (1) An Earth 
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vertical axis rotation (EVAR) for 90s. This was considered the per-rotary stimulation. (2) 
An off vertical axis rotation (OVAR) immediately after the first EVAR with a tilt angle 
of 15º and the same rotational velocity of 60º/s for 120s. The purpose of the OVAR was 
to induce motion sickness symptoms. After the 120s the chair was brought back to 
vertical position and the rotation continued for 60s in the same direction. (3) The Second 
EVAR stopped the rotation of the chair in 1s. This caused a post-rotary stimulation in the 
opposite direction for 90s.12 
 After the experimental session, motion sickness symptoms were assessed using 
the Pensacola diagnostic index methodology. This yields a score between 0 (no 
symptoms) to 61 (maximum symptoms).19 Eye movements, including peak slow phase 
velocity and time constant (TC), were recorded using video-oculography. The mean 
values of TC and gain (as measured by the ratio between slow phase velocity and 
constant head rotation velocity) were calculated from clockwise and counterclockwise 
examinations. The data were then pooled since no significant differences were observed 
within the examinations. The data were presented as means and standard deviations.12 
 During the sinusoidal rotation, the VOR gain was 27% lower in the skater group 
(0.44 ± 0.12 vs. 0.58 ± 0.01; P<0.01). During the velocity rotation, the VOR gain was 
again lower (32%) in the skater group as compared to the control group (0.52 ± 0.14 vs. 
0.71 ± 0.12; (p<0.01). There was no reported difference in the TC between the two 
groups (10.8 ± 1.8s vs. 10.5 ± 2.7s; p=0.78). The motion sickness score was much lower 
in the skater group as compared to the control group (2.8 ± 2.8 vs. 16.2 ± 13.7; p<0.01, 
pvariances <0.00001).12 
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 The authors concluded that skaters, at a young age, can exhibit vestibular 
habituation and reduced susceptibility to motion sickness. They do point out further trials 
conducted with adult subjects is warranted since the vestibular system is still maturing in 
the patient population used here. 
DISCUSSION and RECOMMENDATIONS  
 Dai et al14 demonstrated a decrease in motion sickness symptoms scores and time 
constant after low frequency, low velocity habituation.  This method allowed for no 
significant side effects to the patients, which is a beneficial option compared to other 
available habituation training. The evidence reported by Dai et al14 supports the 
conclusion that visual vestibular habituation can be an effective clinical treatment for 
motion sickness. However this study is not without limitations. Limitations include small 
sample size of 29 subjects, gender bias between groups with 10 of 11 in the motion 
sickness susceptible group being female, lack of randomization and concealment. There 
is also recall bias with participants being expected to self report on symptomology. As an 
observational study, this trial started off with a low GRADE quality of data. This study 
received a single downgrade for having a small sample size. The quality of the evidence 
in this study was then given a GRADE of very low, with an overall significance rating of 
“Not Important”.  
Clement et al10 explored the use of acetylleucine and its effects on vestibular 
training, nystagmus and subjective vertical. As the trial proceeded, the authors found no 
significant difference between the acetylleucine group and the control group for motion 
sickness scores, gain and time constant.  However, the overall pooled data showed 
significant decreases in peak velocity and time constant of the horizontal VOR, as well as 
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an increase in the runs tolerated indicating habituation to the training. The data here 
support the conclusion of habituation for a treatment of motion sickness. The main 
limitation in this study was the small sample size of 20 subjects. There was also a gender 
bias here with all subjects being male. A larger sample size along with a more even 
gender distribution would be helpful to strengthen the data. Furthermore, a separate 
breakdown of male vs. female data could also be beneficial to direct clinical treatment. 
 As a randomized controlled trial, this study started off with a high GRADE quality of 
data. Due to the small sample size, this study also received a single downgrade. The 
quality of the data was given a final GRADE of moderate, with an overall significance 
rating of “Not important.” 
 Tanguy et al12 researched the difference of motion sickness susceptibility between 
figure skaters and age and sex matched controls. The VOR gains for both the sinusoidal 
rotation and velocity rotation phases, as well as the motion sickness symptom scores were 
all lower for the skater group as compared to the controls. This exhibits that a prior 
exposure to visual-vestibular stimulus, such as rotations that are often performed by 
figure skaters, can lead to habituation to motion sickness. Again this trial supports the 
conclusion that visual vestibular habituation can be an effective treatment for motion 
sickness. This study does have limitations such as the small sample size of 22 subjects, 
gender bias with all subjects being female and narrow age distribution ranging from 11-
19 years old. However, data from the younger patient population used here, indicates 
visual vestibular habituation training should not be limited to adult subjects alone. 
Further randomized controlled trials with larger, gender matched, patient population in 
this age group could lead to more supporting data for visual vestibular habituation as a 
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clinical treatment.  This observational study started off with a low GRADE quality of 
evidence. Due to a small sample size, this study also received a single downgrade. The 
final quality of the data here was given a very low GRADE quality of data with an 
overall significance rating of “Not important”. 
CONCLUSION 
 Visual-vestibular habituation has demonstrated promise as a clinical option for the 
treatment of motion sickness. The benefits of this treatment outweigh the risks. Of the 
three articles included in this systematic review, the overall combined quality of the 
evidence, as evaluated by GRADE, is low.  At this time, a weak recommendation at most 
for the use of visual-vestibular habituation for the treatment of motion sickness can be 
given. Further randomized controlled clinical trials with larger patient populations are 
needed to better assess the potential of visual vestibular habituation, and give a non-
pharmacologic treatment option for motion sickness. 
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TABLES 
Table 1. Characteristics of Studies 
            Outcomes 
Type of Study 
Number of 
Subjects Gender 
Age range 
(in years) Blinding Randomization Motion sickness symptom scores 
Time Constant 
(TC) 
Prolonged reduction of motion sickness sensitivity by visual-vestibular habituation. Daj et al 
Observational 29 19F, 10M 25-45 No Blinding Not Randomized 13.0 +/- 4.4 before,  1.5 +/- 3.1 after habituationa -0.32%, -21% * 
Effects of vestibular training on motion sickness, nystagmus, and subjective verticle. Clement et al.  
Randomized 
Controlled Trial 20 0F, 20M 20-40 Double Blind Randomized 
Data pooled between groups. Overall scores decreased as 
number of runs increasedb -22.7% 
Vestibulo-ocular reflex and motion sickness in figure skaters. Tanguy et al. 
Observational 22 22F, 0M 9-19 No Blinding Not randomized 2.8+/-2.8 in skater group vs. 16.2 +/-13.7 in controlsc 
No significant 
difference between 
groups** 
 
a Motion sickness symptom scale ranged from 0-20. 
* -32% for susceptible subjects and -21% for normal subjects after 1st habituation session. 
b Motion sickness symptom scale ranged from 0-51. 
c Motion sickness symptom scale ranged from 0-61. 
** (2.8 +/- 1.8s; 10.5 +/- 2.8; P=0.78) 
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 Table 2. Summary of Findings 
 
 
 
 
 
Quality assessment 
No of patients receiving 
habituation 
        
        
No of 
studies Design 
Risk of 
bias Inconsistency Indirectness Imprecision 
Other 
considerations Experimental Control Importance Quality 
Overall 
Quality of 
Data 
Prolonged reduction of motion sickness sensitivity by visual-vestibular habituation. Daj et al14     
1 observational studies 
no 
serious 
risk of 
bias 
no serious 
inconsistency 
no serious 
indirectness serious* none 10 18 
NOT 
IMPORTANT 
⊕ΟΟΟ     
VERY LOW 
    
Effects of vestibular training on motion sickness, nystagmus, and subjective verticle. Clement et al10     
1 randomised trials 
no 
serious 
risk of 
bias 
no serious 
inconsistency 
no serious 
indirectness serious* none 10 10 
NOT 
IMPORTANT 
⊕⊕⊕Ο LOW 
MODERATE 
    
Vestibulo-ocular reflex and motion sickness in figure skaters. Tanguy et al12     
1 observational studies 
no 
serious 
risk of 
bias 
no serious 
inconsistency 
no serious 
indirectness serious* none 11 11 
NOT 
IMPORTANT 
⊕ΟΟΟ     
VERY LOW 
    
           
  
*Small sample size used in this trial. 
        
